Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma. - Borgers JSW; van Wesemael TJ; Gelderman KA; Rispens T; Verdegaal EME; Moes DJAR; Korse CM; Kapiteijn E; Welters MJP; van der Burg SH; van Houdt WJ; van Thienen JV; et al. (Journal for immunotherapy of cancer, 2024)